6-mercaptopuroine

also known as 6-MP

Also used as a comparator or background therapy in 1 trial

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 3	NCT00488605 Comparator	Aug 2023	leukemia	University of New Mexico	Withdrawn	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	6-mercaptopuroine	ClinicalTrials.gov intervention name — accepted as the source's own label NCT00488605 ↗
Known as	6-MP	“6-MP by mouth daily until the end of month 12.” NCT00488605 ↗
Route	Oral	“6-MP by mouth daily until the end of month 12.” NCT00488605 ↗